Evidence map›Paper›PMID 36158891›Full record

ArticleBioMed research international2022

Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of

Xiaomeng Hu, Shengchao Zhao, Yi Cai, Shasank S Swain, Liangliang Yao, Wei Liu, Tingdong Yan

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Xiaomeng HuUniversity and College Key Lab of Natural Product Chemistry and Application in Xinjiang, School of Chemistry and Environmental Science, Yili Normal University, Yining 835000, China.
Shengchao ZhaoUniversity and College Key Lab of Natural Product Chemistry and Application in Xinjiang, School of Chemistry and Environmental Science, Yili Normal University, Yining 835000, China.
Yi CaiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China.ORCID https://orcid.org/0000-0003-2296-222X
Shasank S SwainDivision of Microbiology and NCDs, ICMR-Regional Medical Research Centre, Bhubaneswar, 751023 Odisha, India.ORCID https://orcid.org/0000-0001-5089-8304
Liangliang YaoAffiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China.ORCID https://orcid.org/0000-0002-8435-5954
Wei LiuUniversity and College Key Lab of Natural Product Chemistry and Application in Xinjiang, School of Chemistry and Environmental Science, Yili Normal University, Yining 835000, China.ORCID https://orcid.org/0000-0002-4404-6348
Tingdong YanSchool of Life Sciences, Shanghai University, 99 Shangda Road, Shanghai 200444, China.ORCID https://orcid.org/0000-0002-5193-022X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sought to explore the anticancer mechanism of

Indexed as

Drugs, Chinese HerbalNeoplasmsCaspase 3ErbB ReceptorsHumansMedicine, Chinese TraditionalMolecular Docking SimulationNetwork PharmacologyReceptors, EstrogenTumor Necrosis FactorsCaspase 3Drugs, Chinese HerbalErbB ReceptorsReceptors, EstrogenTumor Necrosis Factors

Identifiers

PMID36158891
PMCPMC9507705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.